Verastem Balance Sheet Health
Financial Health criteria checks 5/6
Verastem has a total shareholder equity of $32.2M and total debt of $40.7M, which brings its debt-to-equity ratio to 126.2%. Its total assets and total liabilities are $126.4M and $94.2M respectively.
Key information
126.2%
Debt to equity ratio
US$40.65m
Debt
| Interest coverage ratio | n/a |
| Cash | US$113.18m |
| Equity | US$32.22m |
| Total liabilities | US$94.16m |
| Total assets | US$126.38m |
Recent financial health updates
Recent updates
Verastem: Narrowed Market And Less Compelling Efficacy Warrant Rating Downgrade
May 26Verastem: Moving Forward
Sep 13Health Check: How Prudently Does Verastem (NASDAQ:VSTM) Use Debt?
Sep 01
Verastem Non-GAAP EPS of -$0.11 in-line
Aug 08Verastem: Looking Increasingly Attractive
Jun 29Verastem: Time To Take My Position Out Of Mothball
Apr 19Vectoring In On Verastem
Jan 12Verastem: Buying Opportunity Following Unjustified Sell-Off
Sep 22Financial Position Analysis
Short Term Liabilities: VSTM's short term assets ($120.7M) exceed its short term liabilities ($37.4M).
Long Term Liabilities: VSTM's short term assets ($120.7M) exceed its long term liabilities ($56.8M).
Debt to Equity History and Analysis
Debt Level: VSTM has more cash than its total debt.
Reducing Debt: VSTM's debt to equity ratio has reduced from 632.7% to 126.2% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: VSTM has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: VSTM has less than a year of cash runway if free cash flow continues to grow at historical rates of 6.7% each year.